0000103623-24-000074.txt : 20240821 0000103623-24-000074.hdr.sgml : 20240821 20240821161853 ACCESSION NUMBER: 0000103623-24-000074 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240821 DATE AS OF CHANGE: 20240821 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 241228951 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SINGLETON J MATTHEW CENTRAL INDEX KEY: 0001243514 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 286 STANWICH ROAD CITY: GREENWICH STATE: CT ZIP: 06830 144 1 primary_doc.xml 144 0001243514 XXXXXXXX LIVE 0001607678 Viking Therapeutics, Inc. 001-37355 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660 SINGLETON J MATTHEW Director common Oppenheimer & Co Inc

85 Broad Street New York NY 10004

5700 397404.00 110268210 08/21/2024 NASDAQ common 01/03/2017 NQSO Issuer N 5700 01/03/2017 N/A N Oppenheimer & Co Inc

85 Broad Street New York NY 10004

common 08/19/2024 16000 995360.00 Oppenheimer & Co Inc

85 Broad Street New York NY 10004

common 08/14/2024 20786 1195735.00 8/21 shares being sold pursuant to 10b5-1 trading plan on file dated 05/16/2024 08/21/2024 05/16/2024 J Matthew Singleton